Reports related to this article:
Pharmaceuticals company Boehringer Ingelheim expects to invest more than $50 million in its Xochimilco plant in Mexico, with the aim of increasing and improving production by its diabetes segment in the next three years. The company also plans to invest $25 million in its veterinary products plant in Guadalajara, with an expansion to be completed in 2021.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Explore Our Tools
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
View ReportsIndustry Intel
-
Innovations Shaping the Next Era of Power GenerationPodcast Episode / May 22, 2026
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026
-
2026 North American Labor OutlookPodcast Episode / Apr 24, 2026
-
2026 European Metals & Minerals Project Spending OutlookPodcast Episode / Apr 7, 2026
-
The Age of Critical Minerals in the AmericasPodcast Episode / Mar 20, 2026